Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 4 Similar Profiles
Mutation
Medicine & Life Sciences
Hemochromatosis
Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Medicine & Life Sciences
Genetic Testing
Medicine & Life Sciences
Iron Overload
Medicine & Life Sciences
Polymerase Chain Reaction
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Phosphotransferases
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1991 2006
- 3 Finished
Bcr-Abl RNA levels to monitor STI571 leukemia therapy
2/14/03 → 1/31/06
Project: Research project › Exploratory/Developmental Grants
Leukemia
RNA
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Therapeutics
Imatinib Mesylate
Oncogene Proteins
Transcription Factor TFIIB
Trans-Activators
Gene Expression
myb Genes
STRUCTURE AND FUNCTION OF MYB ONCOGENE IN NEURONAL CELLS
7/1/91 → 6/30/94
Project: Research project › Clinical Investigator Award (CIA)
myb Genes
Neuroblastoma
Proto-Oncogene Proteins c-myb
Brain
Internship and Residency
Research Output 1982 2018
Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS
Alberti, M. O., Srivatsan, S. N., Shao, J., McNulty, S. N., Chang, G. S., Miller, C. A., Dunlap, J. B., Yang, F., Press, R. D., Gao, Q., Ding, L., Heusel, J. W., Duncavage, E. J. & Walter, M. J., Jun 29 2018, (Accepted/In press) In : Leukemia. p. 1-5 5 p.Research output: Contribution to journal › Article
Artifacts
Mutation
Neoplasms
1
Citations
Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential
Raess, P. W., Cascio, M. J., Fan, G., Press, R., Druker, B. J., Brewer, D. & Spurgeon, S. E., Jan 1 2017, In : American Journal of Hematology. 92, 1, p. E6-E8Research output: Contribution to journal › Letter
Large Granular Lymphocytic Leukemia
Hematopoiesis
Mutation
5
Citations
CRISPR-Cas9–mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy
Ma, L., Boucher, J. I., Paulsen, J., Matuszewski, S., Eide, C. A., Ou, J., Eickelberg, G., Press, R. D., Zhu, L. J., Druker, B. J., Branford, S., Wolfe, S. A., Jensen, J. D., Schiffer, C. A., Green, M. R. & Bolon, D. N., Oct 31 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 44, p. 11751-11756 6 p.Research output: Contribution to journal › Article
Clustered Regularly Interspaced Short Palindromic Repeats
Drug Resistance
Mutagenesis
Mutation
Oncogenes
DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML
Ma, J., Dunlap, J., Paliga, A., Traer, E., Press, R., Shen, L. & Fan, G., Nov 23 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.Research output: Contribution to journal › Article
Cytogenetics
Mutation
Genes
Cohort Studies
Recurrence
1
Citations
Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practices
Arora, R. & Press, R. D., Jan 2 2017, In : Leukemia and Lymphoma. 58, 1, p. 8-16 9 p.Research output: Contribution to journal › Review article
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Practice Guidelines
RNA
Protein-Tyrosine Kinases
Real-Time Polymerase Chain Reaction